173 related articles for article (PubMed ID: 38662250)
1. The Impact of Metabolic Bariatric Surgery on Cardiovascular Diseases in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
Esparham A; Shoar S; Mehri A; Khorgami Z; Modukuru VR
Obes Surg; 2024 Jul; 34(7):2338-2346. PubMed ID: 38662250
[TBL] [Abstract][Full Text] [Related]
2. The association of bariatric surgery with myocardial infarction and coronary revascularization: a propensity score match analysis of National Inpatient Sample.
Esparham A; Roohi S; Abdollahi Moghaddam A; Anari Moghadam H; Shoar S; Khorgami Z
Surg Obes Relat Dis; 2024 Apr; ():. PubMed ID: 38744643
[TBL] [Abstract][Full Text] [Related]
3. Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.
Lee HH; Lee HA; Kim EJ; Kim HY; Kim HC; Ahn SH; Lee H; Kim SU
Gut; 2024 Feb; 73(3):533-540. PubMed ID: 37907259
[TBL] [Abstract][Full Text] [Related]
4. Impact of metabolic dysfunction-associated steatotic liver disease on COVID-19 hospitalizations: A propensity-matched analysis of the United States.
Sohail A; Ali H; Patel P; Subramanium S; Dahiya DS; Sohail AH; Gangwani MK; Satapathy SK
World J Virol; 2024 Mar; 13(1):91149. PubMed ID: 38616849
[TBL] [Abstract][Full Text] [Related]
5. Recompensation in MASLD-related cirrhosis via metabolic bariatric surgery.
Feng G; Han Y; Yang W; Shikora S; Mahawar K; Cheung TT; Targher G; Byrne CD; Hernandez-Gea V; Tilg H; Zheng MH
Trends Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38908982
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis.
Kumar J; Mohsin S; Hasan M; Bilal AR; Ali KM; Umer A; Hadi DZM; Nandlal S; Kumar S
Clin Res Hepatol Gastroenterol; 2024 Jan; 48(1):102261. PubMed ID: 38070828
[TBL] [Abstract][Full Text] [Related]
7. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study.
Moon JH; Jeong S; Jang H; Koo BK; Kim W
EClinicalMedicine; 2023 Nov; 65():102292. PubMed ID: 37954905
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular complications during delivery hospitalizations in patients with nonalcoholic fatty liver disease in pregnancy.
Niu C; Zhang J; Khalid N; Zhu K; Syed T; Liu H; Okolo PI
Eur J Gastroenterol Hepatol; 2024 Jun; ():. PubMed ID: 38874917
[TBL] [Abstract][Full Text] [Related]
9. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up.
Choe HJ; Moon JH; Kim W; Koo BK; Cho NH
Metabolism; 2024 Apr; 153():155800. PubMed ID: 38266957
[TBL] [Abstract][Full Text] [Related]
10. Bariatric Surgery and Cardiovascular Disease Risk in Patients with Pulmonary Hypertension: A Propensity Score Matched Analysis of US National Inpatient Sample.
Esparham A; Shoar S; Mehri A; Modukuru VR
Obes Surg; 2023 Oct; 33(10):3230-3236. PubMed ID: 37639208
[TBL] [Abstract][Full Text] [Related]
11. Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.
Yanai H; Adachi H; Hakoshima M; Iida S; Katsuyama H
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895151
[TBL] [Abstract][Full Text] [Related]
12. Association of Metabolic Dysfunction-Associated Steatotic Liver Disease/Non-alcoholic Fatty Liver Disease With Type 2 Diabetes Mellitus: A Case-Control Study in a Tertiary Care Hospital in Pakistan.
Zahoor F; Saeed NU; Javed S; Sadiq HZ; Mand Khan F; Haider M; Shafqat MN; Maqbool A; Chaudhry A
Cureus; 2023 Oct; 15(10):e47240. PubMed ID: 38021965
[TBL] [Abstract][Full Text] [Related]
13. Adverse pregnancy outcomes as a risk factor for new-onset metabolic dysfunction-associated steatotic liver disease in postpartum women: A nationwide study.
Jung YM; Lee SM; Wi W; Oh MJ; Park JS; Cho GJ; Kim W
JHEP Rep; 2024 Apr; 6(4):101033. PubMed ID: 38524668
[TBL] [Abstract][Full Text] [Related]
14. Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study.
Valenzuela-Vallejo L; Chrysafi P; Kouvari M; Guatibonza-Garcia V; Mylonakis SC; Katsarou A; Verrastro O; Markakis G; Eslam M; Papatheodoridis G; Mingrone G; George J; Mantzoros CS
Metabolism; 2023 Nov; 148():155694. PubMed ID: 37757973
[TBL] [Abstract][Full Text] [Related]
15. The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysis.
Lv Q; Zhao H
Ann Med; 2024 Dec; 56(1):2306192. PubMed ID: 38253023
[No Abstract] [Full Text] [Related]
16. Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification.
Kang MK; Song J; Loomba R; Park S; Tak W; Kweon Y; Lee Y; Park JG
Res Sq; 2024 Mar; ():. PubMed ID: 38496485
[TBL] [Abstract][Full Text] [Related]
17. Metabolic dysfunction-associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis.
Kobayashi N; Tada T; Nishimura T; Matono T; Yuri Y; Takashima T; Aizawa N; Ikeda N; Fukunishi S; Hashimoto M; Ohyanagi M; Enomoto H; Iijima H
Hepatol Res; 2024 May; 54(5):429-438. PubMed ID: 38015179
[TBL] [Abstract][Full Text] [Related]
18. Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009-2020.
Igwe JK; Surapaneni PK; Cruz E; Cole C; Njoku K; Kim J; Alaribe U; Weze K; Mohammed B
Obes Surg; 2023 Nov; 33(11):3472-3486. PubMed ID: 37804470
[TBL] [Abstract][Full Text] [Related]
19. The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque.
Huang Y; Wang Y; Xiao Z; Yao S; Tang Y; Zhou L; Wang Q; Xie Y; Zhang L; Zhou Y; Lu Y; Zhu W; Chen M
BMC Cardiovasc Disord; 2023 Nov; 23(1):554. PubMed ID: 37951879
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of metabolic dysfunction-associated steatotic liver disease in acute myocardial infarction: A propensity score-matched analysis.
Kong G; Cao G; Koh J; Chan SP; Zhang A; Wong E; Chong B; Jauhari SM; Wang JW; Mehta A; Figtree GA; Mamas MA; Ng G; Chan KH; Chai P; Low AF; Lee CH; Yeo TC; Yip J; Foo R; Tan HC; Huang DQ; Muthiah M; Chan MY; Loh PH; Chew NWS
Diabetes Obes Metab; 2024 May; ():. PubMed ID: 38779875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
